New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
GENETIC TECHNOLOGIES (GENE)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
Topic Listing for GENETIC TECHNOLOGIES
Aasb 102 107 108 110 112 114 116
Aasb 108 Accounting Policies Changes Estimates Errors
Aasb 123 Revised 2007-6 Borrowing Costs Consequential Amendments
Aasb 134 Interim Financial Reporting
Aasb Business Combinations
Aasb Financial Instruments Disclosures 2005-10 Amendments Australian Accounting
Aasb Interpretation Group Treasury Share Transactions
Aasb Operating Segments
Aasb Share-based Payments
Aasb Transitional Exemptions
Aasb-i Interim Financial Reporting Impairment
Abn 009 212 328
Account Number 700390978
Accountants
Accounting Changes Error Corrections
Accounting Estimates
Accounting Estimates Errors
Accounting Impairment Disposal Long-lived Assets
Accounting Income Taxes
Accounting Nonmonetary Transactions
Accounting Standards
Accounting Standards Means
Accounting Stock Issued Employees
Accounts
Accounts Payable
Accounts Receivable
Accruals Employee Entitlements
Accumulated Losses
Acknowledgments Guarantor
Acn 009 212 328
Acquired Separately Business Combination
Acquisitions Disposals Business Entities
Actn Alpha-actinin
Actn3
Add Notes Necessary Understanding Position See Aasb 1026
Addictive States
Additional Remuneration Extra Services
Adjournment General Meeting
Administration Expenses
After Completion Vendors
Agent Attorney
Agreement Terminated Prior Completion Purchaser Return Vendors
Agreement Unless Context Otherwise Requires
Allotment Issue Shares Control Directors
Amendment Dividend Reinvestment Plans
American Depositary Shares
American Depositary Shares Each Representing Ordinary Evidenced Receipts
Ancestral Haplotypes Tissue Typing Patents
Animal Testing
Animals
Announcements
Annual General Meeting
Annual General Meetings
Antiparasitic Patents
Appendix
Appendix Final Directors Interest Notice
Appendix Licensed Patents
Application Patent Re-examination
Appointment Favour
Appointment Ian Nisbet Strategic Advisor
Appointment New Director
Appointment New Directors
Appointment Non-executive Chairman
Apportionment Dividends
Assets
Assignment
Associate Professor Robert Richards
Asx Appendix
Asx Appendix Cont
Asx Principles Recommendations
Athletic Performance Testing
Attestation Report Registered Public Accounting Firm
Attorney Member
Audit Approach
Audit Committee
Audit Committee Financial Expert
Audit Committee Pre-approval Policies Procedures
Audit Opinion
Auditor
Auditor Cannot Director
Auditor Independence
Auditors
Auditors Independence Declaration
Auditors Independence Declaration Directors Genetic Technologies Limited
Auditors Opinion
Auditors Responsibility
Australia
Australian Death Duty
Australian Tax Consequences
Authorisation
Authorisations
Authority
Auto-immune Diseases
Available-for-sale Investments
Available-for-sale Investments Non-current
Background
Background History Paternity Testing Business
Basis Accounting Statement Compliance
Basis Commitments
Basis Consolidation
Basis Preparation
Basis Preparation Half-year Financial Report
Basis Presentation
Because Not Necessarily Required Provide Same Information Issuer
Because Not Required Provide Same Information Issuer Securities
Bioscentia Institut Fur Medizinische Diagnostik Gmbh
Board Directors Shareholders Genetic Technologies Limited
Board Responsibility
Books Records
Brokerage
Business
Business Activities
Business Combination
Business Names
Business Segments
Camelot Accreditation
Camelot Farms Means Person Trading Being Sharyn Conole
Cancellation Certificate Transfer
Cancer Susceptibility Testing
Capital Expenditure Commitments
Capital Management
Capital Structure
Capitalising Profits
Carry Forward Profits
Case Trust Includes Interests Available Responsible Entity
Cash Bank Debtors
Cash Consideration
Cash Equivalents
Cash Equivalents Reconciliation
Cash Used Operations
Casting Vote Chairman
Catherine Barclay
Ceo Succession Plan
Certain Circumstances Holders Adrs Limited Rights Relative Ordinary
Certificate Joint Holders
Certificated Holdings
Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act
Cgt
Chairman Board Meetings
Chairman General Meeting
Changes Capital Structure
Changes General Meeting
Changes Internal Control Over Financial Reporting
Chess
Chief Executive Officer
Chief Financial Officer Secretary
Chief Scientific Officer
Clarification Announcements
Clause
Clause Ceases Effect Following Announcement Takeover Bid
Code Ethics
Collaborative Research Agreement
Collaborative Research Agreement Pathogen Genomics Genetics Program Pggp
Collaborative Research Agreement University Melbourne Pathogens Project
Commentary Financial Results
Commercial Licensees
Committee Membership
Committee Powers Meetings
Committees Board
Competition
Competitors Develop Effective Products Results Operations Financial Condition
Completion
Completion Conditional
Completion Contracts
Completion Subject Vendors Complying Obligations Clause Purchaser
Completion Vendors
Compliance Ifrs
Compliance Nasdaq Rules
Compliance Settlement Rules
Compliance Statement
Comprehensive Income
Comprehensive Loss
Computer Software
Concentrations Credit Risk
Concentrations Credit Risk Cont
Conclusion
Condition
Conducting Poll
Confidential Information
Confidentiality
Conflict Other Obligations
Connor Erade Village Foundation
Consent Sanction Required Redemption
Consents Approvals
Consequential Amendments Other Australian Accounting Standards
Consideration
Consideration Guarantor
Consolidated Statement Cash Flows
Consolidated Statements Other Financial Information
Consolidation Variable Interest Entities
Constitution
Constitution Subject Act
Constitution Subject Listing Rules Listed
Consumables
Contents Notice General Meeting
Contingencies
Contingent Assets
Contingent Assets Liabilities
Contingent Liabilities
Contract Research Trial Expenses
Contracts
Contributed Equity
Controlled Person
Controlling Person
Controls Procedures
Convening Directors Meeting
Corporate
Corporate Governance Committee
Corporate Governance Statement
Corporate Information
Corporate Structure
Corporations Act 2001
Corporations Act 2001 Listing Rules Definitions
Corporations Regulations 2001
Cost Goods Sold
Cost-method Investments
Costs
Counting
Credit Risk
Credit Risk Exposures
Critical Accounting Estimates
Cryptosporidium
Cyo O8217connor Erade Village Foundation
David Carruthers
Deal Proceeds Sale
Dealing Fractions
Death Member
Deferred Revenue
Deferred Revenue Cont
Deferred Revenue Current
Definitions
Deposit Proxy
Deposits Non-current
Derive Revenues
Details Key Management Personnel
Development Stage Enterprise
Dickstein Shapiro Morin Oshinsky Llp
Difference Terms Issue Calls
Difficulty Effecting Service Legal Process Enforcing Judgments Against
Direction Genetic Research
Direction Genetic Testing
Director
Director Act Professional Capacity
Director Not Vote Contract Material Personal Interest
Director Regarded Present Meeting
Directors
Directors Act Notwithstanding Vacancy
Directors Cause Keep
Directors Confer Powers Executive
Directors Declaration
Directors Declare Interest
Directors Declare Potential Conflicts
Directors Declaring Dividend
Directors Deduct Dividends Money Payable
Directors Fill Casual Vacancies Appoint Additional
Directors Make Calls
Directors Meet Either
Directors Not Disqualified Holding Office Contracting
Directors Powers Relation Capitalisation Profits
Directors Report
Directors Responsibility Financial Report
Directors Responsibility Half Consolidated Financial Report
Directors Responsibility Half-year Financial Report
Directors Retain Certain Dividends
Directors Tenure Office
Directors Vote Shares Other Corporations
Disclosure Controls Procedures
Disclosures
Disposal Joint Venture Interest
Dispute
Dispute Not Resolved Clause 613 Parties Appoint Expert
Dispute Notice
Distribution Specie
Distribution Surplus Assets
Dividend
Dividend Reinvestment Plans
Dividends
Dividends Only Payable Out Profits
Dividends Paid Proposed
Dividends Payable Foreign Currency
Dividends Paying Agents
Dna Deoxyribonucleic Acid
Dna Solutions
Dnalabs
Documents Display
Documents Tabled Meeting
Dual Residency
Each Party Irrevocably Unconditionally
Early Adoption Standard
Earnings Per Share
Ecember 2006
Effect Forfeiture
Effective Date
Election Registration Transmission
Electronic Communications
Electrophoresis Standards Patents
Eligibility Election Director
Employee Benefits
Employee Benefits Expenses
Employee Superannuation
Employees
Employment Contracts
Enetic Echnologies Imited
Enforcement Liabilities Service Process
Entire Agreement
Entitlement Member Certificate
Environmental Laws
Environmental Regulation Performance
Environmental Regulations
Ethical Other Concerns Surrounding Genetic Information Reduce Demand
Events After Balance Sheet Date
Evidence Forfeiture
Evidence Sale Accordance Clause
Evidenced American Depositary Receipts
Exceptions
Exchange Controls Other Limitations Affecting Security Holders
Exchanges Nonmonetary Assets
Execution Version
Executive
Executive Director Secretary Senior Management Remuneration
Executive Director Senior Management Remuneration
Executive Remuneration
Executives
Exemption Lien
Exemption Requirement Restate Comparative Information Aasb 132 139
Exercise Rights Registered Shareholder
Expenses Directors
Expert
Expert Directed Parties Settle Matter Dispute Within Business
Extent Lien
Extent Permitted Law
Fact Not Expect Pay Cash Dividends Lead Decreased
Fair Value Estimation
Fair Value Measurements
Fair Value Option Financial Assets Liabilities
Family Relationships
Fax
Fee Paid Liquidator Approved General Meeting
Fetal Cell Recovery Patents
Final Directors Interest Notice
Finance Costs
Finance Leases Hire Purchase Agreements
Financial Records
Financial Report Directors Responsibility
Financial Report Remuneration Disclosures Directors Responsibility
Financial Risk Management
Financial Statements
Financial Statements Audited
Financing Facilities Available
Finders Fees
Fixed Payments Deemed Calls
Fixed Remuneration
Forecasts Given Purchaser Advisers
Foreign Currencies
Foreign Currency Risk
Foreign Currency Risk Cont
Foreign Currency Translation
Foreign Currency Translation Reserve
Foreign Exchange Rate Risk Exposures
Forensic Testing
Forensics
Forfeit Instead
Forfeiture Non-payment Calls
Form 20-f
Form Proxy
Formation
Forward-looking Statements
Fred Bart
Further Assurances
Future Cash Needs
Gary Cobon
Gendia
Gene-e
General
General Administrative Expenses
General Definitions Relationships Among
General Meeting
General Meetings
General Obligations
General Warranties
Genetic Technologies Limited
Genetic Technologies Limited Abn 009 212 328
Genetic Testing
Genetic Testing Animals
Genetic Testing Diagnostics
Genetic Testing Expenses
Genetic Testing Forensics
Genetic Testing Paternity
Genetic Testing Plants
Genetic Testing Revenues
Genetic Testing Sports Performance
Genetic Tests
Genetic Variability
Genomic Mapping Patents
Genomic Matching Technique
Genomics
Geoffrey Newing
Geographic Information
Goods Services Tax
Goodwill
Government Agency
Government Regulation Genetic Research Testing Adversely Affect Demand
Government Regulation Geneticresearch Testing Adversely Affect Demand Products
Government Regulation Geneticresearch Testing Adversely Affect Demand Services
Grant Income
Grant Revenues
Grants Licensee Direct Customers
Gribbles
Group General Manager Business Development
Group General Manager Intellectual Property
Group Overview
Gst
Gtech International Resources Limited
Gtg
Gtg Appoints New Chief Executive Officer
Gtg Licenses Monsanto
Gtg Non-coding Patents
Guarantee Guarantor
Half-year
Half-year 2005
Hanover Street Fitzroy Victoria 3065 Australia
Healthcare Bio-sciences Corp
Henry Bosch
Hire Purchase Commitments
Hire Purchase Finance Liability
Historical Cost Convention
Historical Cost Convention`
History Development
History Losses Expect Continue Incur Costs
Holders
Holders Adss Limited Rights Relative Ordinary Shares Certain
Horticulture Australia Limited
Huw Jones
Ian Christensen
Ian Smith
Identification Reportable Segments
Imited
Immunaid
Immune Response
Impairment
Impairment Assets Other Goodwill
Impairment Goodwill
Impairment Intangible Assets Goodwill
Impairment Long-lived Assets
Impairment Losses Other Write-downs
Impairment Notes
Impairment Patents
Impairment Patents Cont
Important Relationships External Parties Over Limited Control
Income Tax
Income Tax Cont
Income Taxes
Income Withholding Taxes
Indemnification Disclaimer Warranties
Indemnification Insurance Directors Officers
Indemnification Insurance Respect Directors
Indemnities Contained Agreement
Indemnity
Independence
Independent Audit Report Members Genetic Technologies Limited Scope
Independent Auditors Report Members Genetic Technologies Limited
Index
Index Consolidated Financial Statements
Industrial Relations
Industry Background
Information Contractual Obligations
Information Documents Not Available Now Given Asx Soon
Information Reporting Backup Withholding
Information True Accurate
Insolvency Events
Instrument Appointing Proxy
Insurance
Intangible Assets
Intangible Assets Goodwill
Intangible Assets Goodwill Cont
Intellectual Property Rights
Interest Expense
Interest Income
Interest Joint Venture Operation
Interest Rate Risk
Interest Rate Risk Exposures
Interest Received
Interest Revenue
Interest Sums Not Paid
Interest-bearing Liabilities Current
Interest-bearing Liabilities Non-current
Interests Experts Counsel
Interests Shares Options Related Bodies Corporate
Interference Proper Astc Transfer
Interpretation
Introduction
Intron Sequence Analysis Patents
Investments Other Financial Assets
Investor Relations
Issue Certificates
Issue Preference Shares
Issued Share Capital
John Dawkins
John Tonge Centre
Joint Holders
Joint Ventures
Jonathan Whitty
Jurisdictions Incorporation Registration Applicable Conduct Business
Kings College London
Leanne Rowe
Leasehold Properties
Leasehold Properties Property Leases
Leases
Leases Hire Purchase Agreements
Least Business Before Completion Date
Least Business Before Completion Date Vendors Give Purchaser
Legal Patent Fees
Liabilities
Licences
License Agreement
License Fee Income
License Fees Received
License Revenues
License Revenues Annuities
Licensed Patents
Licenses Commercial Collaborations
Licensing
Licensing Cont
Lien
Likely Developments Expected Results
Limitations Effectiveness Controls
Limited Liability Members
Liquidity Funding
Liquidity Risk
Liquidity Risk Cont
Listing Rules
Listing Rules Settlement Only Effect Listed
Litigation
Litigation Other Legal Proceedings
Loan Account
Loans Other Receivables
Long Term Incentive Lti
Loss Per Share
Luisa Ashdown
Major Customers
Major Shareholders
Managements Annual Report Internal Control Over Financial
Managements Annual Report Internal Control Over Financial Reporting
Managing Director
Markers Disease Patents
Market Risk
Marketable Parcel
Marketable Securities
Marketing Promotion Expenses
Markets
Material Contracts
Matters Since Accounts Date
Maxxam Analytics Inc
Medical Diagnostics
Medvet Science Pty Ltd
Meeting Competent Exercise Powers
Melbourne Australia 2006 Genetic Technologies Limited Gtg Nasdaq
Melbourne Australia Monday 2006 Genetic Technologies Limited Gtg
Melbourne Australia Monday 2009 Genetic Technologies Limited Nasdaq
Melbourne Australia Tuesday 2006 Genetic Technologies Limited Gtg
Melbourne Australia Tuesday 2007 Genetic Technologies Limited Nasdaq
Melbourne Australia Tuesday 2009 Genetic Technologies Limited Nasdaq
Melbourne Australia Wednesday 2006 Genetic Technologies Limited Gtg
Member
Member Deemed Present
Members Requisition Meeting
Mervyn Jacobson
Metamorphix Inc
Method Voting
Michael Ohanessian
Minimis
Minority Interests
Minutes
Minutes Signed Chairman
Modulation Immune System Patents
Molecular Diagnostic Testing
Nasdaq Closing Bell Ceremony
Nasdaq Sec
Nata National Association Testing Authorities Australia
Nature Adrs Australian Taxation Purposes
Nature Adrs Federal Income Tax Purposes
Nature Operations Principal Activities
Nature Purpose Reserves
Net Fair Values Financial Assets Liabilities
Net Foreign Exchange Gains Losses
Net Foreign Exchange Losses
Net Loss Per Share
Net Proceeds
Net Profit Loss Sale Assets
Net Profit Sale Assets
Net Profit Sale Business
New Accounting Standards Interpretation
New Accounting Standards Interpretation Cont
New Accounting Standards Interpretations
Non-audit Services
Non-cash Activities
Non-cash Financing Investing Activities
Non-cash Investing Financing Activities
Non-cash Transactions
Non-coding
Non-executive
Non-executive Chairman
Non-executive Director Remuneration
Non-merger
Non-us Holders
Not Applicable
Notes
Notice
Notice Adjourned Meeting
Notice Calls
Notice Deceased Bankrupt Members
Notice Deemed Served
Notice General Meeting
Notice Meeting
Notice Refusal Register
Notice Unmarketable Parcel Holder
Notices
Notices Binding Transferees
Notices Joint Holders
Number 0-51504
Number Directors
Objection Raised Chairman General Meeting
Objective
Oconnor
Off-balance Sheet Arrangements
Office
Office Director Automatically Vacated
Officers
Official Investigations
Omission Give Notice
Operating Expenses
Operating Financial Review Prospects
Operating Leases
Operating Results
Operations
Optigen
Options
Options Summary
Orchard Road Rmb 8540 Ourimbah Nsw 2258
Ordinary Shares
Organization Nature Operations
Organizational Structure
Other Capital Expenditure Commitments
Other Contingencies
Other Expenditure Commitments
Other Income
Other Related Party Transactions
Other Taxes
Other Transactions Balances Key Management Personnel
Other Transactions Balances Key Management Personnel Related Parties
Out-licensing Non-coding Patents Globally
Overriding Effect Clause
Parasitology Patents
Part
Part Business Names
Part Directors Interests Contracts
Part Directors Relevant Interests Securities Director Not Registered
Part Directors Relevant Interests Securities Director Registered Holder
Part Officers Etc
Part Other
Participation Chess
Party Interest
Party Make Disclosures
Passive Foreign Investment Rules
Patent License Agreement
Patent License Fees
Patent Portfolio
Patentbridge
Patents
Pathogen Genomics Genetics Program Pggp
Pathogens
Pathogens Program
Paul Macleman
Pay Costs
Payables
Payment Calls
Payment Dividends
Payment Goods Services Research
Payments Related Entities Entity Associates
Performance Bond
Performance Bond Deposits
Performance Bond Deposits Current
Permitted Disclosures
Persons Registered
Pggp
Phone
Place Meeting
Plant Equipment
Plant Testing
Poll Demanded Resolution
Pollutant
Post 2006
Postal Address
Potent New Anti-tumor Immunotherapies
Potentially Hazardous Materials Chemicals Patient Samples Business Disputes
Power Alter Capital
Power Buy Back Shares
Power Determine Declare Dividends Vested Directors
Powers Borrow Raise Money
Powers Chairman
Powers Directors
Preparation
Prepayment Calls
Prepayments Other Assets Current
Press
Principal Accountant Fees Services
Principle Lay Solid Foundations Management Oversight
Principle Make Timely Balanced Disclosure
Principle Promote Ethical Responsible Decision Making
Principle Recognise Manage Risk
Principle Remunerate Fairly Responsibly
Principle Respect Rights Shareholders
Principle Safeguard Integrity Financial Reporting
Principle Structure Board Add Value
Principle Structure Board Add Value Cont
Principles Consolidation
Problems Associated International Business Operations Affect Ability License
Proceeds Sale
Proceeds Sale Shares Sold Lien
Prof Colin Masters
Prof Deon Venter
Prof Michael Quinn
Prof Simon Easteal
Professor Colin Masters
Professor Michael Quinn
Professor Norbert Bachl
Professor Simon Easteal
Project
Proof Calls
Properties
Property Leases
Property Plant Equipment
Proposed Pggp
Provision Agreement Invalid Unenforceable Jurisdiction
Provisions
Proxy Demand Join Demanding Poll
Public Market Not Develop Adss Ability Resell Negatively
Purchase Price
Purchaser Indemnifies Vendor Liability Arising Connection
Purchaser Waive Certain Conditions
Purposes Clause
Quantitative Qualitative Disclosures Market Risk
Questions Decided Majority
Quorum
Quorum Board Meetings
Quorum General Meeting
Rarecellect
Reasons Offer Proceeds
Receipt
Receipt Proceeds Sale
Receivables
Receivables Non-current
Recent Accounting Pronouncements
Recent Pronouncements
Recitals
Reclassifications
Recognition Trusts Other Interests
Reconciliation Cash
Reconciliation Cash Equivalents
Reconciliation Goodwill
Reconciliation Minority Interests Subsidiaries
Reconciliation Patents
Reconciliation Reserves
Recoverable Amount Assets
Redemption Forfeited Shares
Reduction Capital
Register
Registered Head Office
Registered Office
Registered Office Jurisdictions Carries Business
Registers
Registration Procedure
Registration Transfer
Rehabilitation Costs
Related Body Corporate
Related Party Transactions
Related Party Transactions Balances
Relation Objection
Release
Relevant Schemes
Reliance
Rely Heavily Patents Proprietary Technology Future Claims Invalid
Rely Services Individuals Possess Special Skills Experience
Remedy Unmarketable Parcel Holder
Remuneration
Remuneration Accordance Listing Rules
Remuneration Executive Directors
Remuneration Key Management Personnel
Remuneration Key Management Personnel Cont
Remuneration Non-executive Directors
Remuneration Philosophy
Remuneration Report Audited
Remuneration Strategy
Remuneration Structure
Rendering Services
Rental Assets
Rental Assets Contracts
Rental Contracts
Replaceable Rules Not Apply
Replacement Certificates
Report Condensed Half-year Financial
Report Financial
Report Half-year Consolidated Condensed Financial
Report Independent Registered Public Accounting Firm
Report Remuneration
Reporting Comprehensive Income
Reports
Representations Warranties
Representative Body Corporate
Research
Research Agreement Kings College London
Research Agreement University Western Australia
Research Development
Research Development Commitments
Research Development Costs
Research Development Expenditure Commitments Cont
Research Development Expenses
Research Development Grants
Research Development Grants Received
Research Licensees
Research Licenses Collaborations
Reserves
Resignation Director
Resolution Determined Majority
Resolution Passed Deemed Determination Board
Resolution Writing
Restricted Securities
Restricted Security Deposits
Restrictions Transfer
Results 2006 Annual General Meeting
Results 2008 Annual General Meeting
Retirement Rotation
Retiring Director Eligible Re-election
Retraction Announcement
Returns Etc
Revaluation Assets
Revenue Recognition
Revenue Recognition Cont
Revenues
Revenues Expenses
Review Approach
Review Financial Condition
Review Interim Financial Report Performed Independent Auditor Entity
Review Results Operations
Revocation Withdrawal Notice
Rights Cumulative
Rights Holders Preference Shares
Risk Management
Robert Edge
Ross Barrow
Royalties
Royalties Annuities
Royalties Annuities Received
Royalties License Fees Commissions Paid
Sale Forfeited Share
Sale Lien
Sale Marketable Securities
Sale Purchase
Sale Shares
Sale Unmarketable Parcels
Sales Cycle Typically Lengthy
Sales Marketing
Sales Marketing Expenses
Sarbanes-oxley 302 Certification
Sarbanes-oxley Act 2002
Scientific Advisors
Scope
Secretary
Secretary Record Declarations Directors
Securities Exchange Act 1934
Securities Financing
Security Interest
Segment Accounting Policies
Segment Disclosures
Segment Products Locations
Segment Reporting
Senior Management
Service Notices
Service Post
Service Testing Expenses
Service Testing Revenues
Settlement Rules
Severability
Share Ownership
Share-based Payment Transactions
Share-based Payments
Share-based Payments Reserve
Share-based Payments Transactions
Shareholdings Membership
Shares Issued Result Exercise Options
Short Term Incentive Sti
Sidney Hack
Signatures
Signed Behalf Genetic Technologies Limited
Significant Accounting Estimates
Significant Accounting Estimates Assumptions
Significant Accounting Estimates Judgements
Significant Changes
Significant Changes State Affairs
Significant Events After Balance Date
Significant Judgements Applying Entitys Accounting Policies
Significant Research Development Agreements
Signing Notices
Sonic Health Care
Sponsored Research Agreement Oconnor
Sponsored Research Agreement Oconnor Erade Foundation
Sponsored Research Agreement Oconnor Erade Village Foundation
Sports Performance
Sports Performance Patents
Staff Share Plan
Stamp Duty
Statement
Statement Compliance
Statement Experts
Stock
Stock Options
Stock Price Volatile Fluctuate Significantly Based Events Not
Structure
Structure Board
Sub-delegation Powers
Subject Clauses Each Party Not Without Prior Written
Subject Professional Liability Suits Insurance Not Sufficient Cover
Subsequent Events
Subsequent Events Cont
Subsidiary Information
Sum
Summary
Summary Significant Accounting Policies
Superannuation Commitments
Supplies Extender Other Products Necessary Process Canine Semen
Support Significant Research Projects
Surrender Shares
Switzerland
T-regulatory Cells
Takeovers Act
Tax
Tax Consolidation
Tax Consolidation Legislation
Tax Consolidation System
Tax Effect Accounting Members Consolidated Group
Tax Sales Other Dispositions Shares Capital Gains
Tax Sales Other Dispositions Shares Stockholders Holding Revenue
Taxation Dividends
Taxes
Telephone 011 9415 1135 Facsimile 9417 2987
Telephone 011-61-3-9415-1135 Facsimile 011-61-3-9417-2987
Term Termination Agreement
Termination Failure Conditions
Terms Conditions
Terms Conditions Contributed Equity
Thomas Howitt
Time Place Completion
Title Purchaser Unmarketable Parcel
Tom Howitt
Total Cash End
Trade Accounts Payable
Trade Accounts Receivable
Trade Accounts Receivable Other Receivables
Trade Licence Agreements
Trade Marks
Trade Other Payables
Trade Other Payables Current
Trade Other Receivables
Trade Other Receivables Current
Transactions Within Group
Transfer Document
Transfer Not Complete Until Name Entered Register
Transfer Sale Lien
Transmission Death Bankruptcy
Treasury Policy
Treasury Related Policies
Trend Information
Trichostrongylus Vitrinus
Ultimate Parent
Unable Protect Proprietary Assets Not Able Commercialize Products
Unable Protect Proprietary Methods Technologies Not Able Commercialize
Uncertainty Income Taxes
Unclaimed Dividends
Une 2008
Unissued Shares Option
United States Federal Income Taxation
Unlisted Directors Options
Unlisted Other Options
Unlisted Placement Options
Unlisted Shares
Unlisted Vendor Options
Unsecured Loan
Until Completion Vendors Cause
Update Regarding Applera Dispute
Useful Lives Assets
Validity Acts Directors
Validity Vote Given Accordance Proxy
Variable Interest Entities
Variable Remuneration
Variable Remuneration Cont
Variable Remuneration Long Term Incentive Lti
Variable Remuneration Short Term Incentive Sti
Variation Cancellation Rights Class Shares
Variation Issue Further Shares Ranking Equally
Vendor Associate
Vendor Associates
Vendors
Vendors Acknowledge
Vendors Acknowledge Agree
Vendors Immediately Disclose Purchaser Anything Arise Become Known
Victoria 3065 Australia
Victorian Institute Forensic Medicine
Votes
Votes Proxy
Voting Call Unpaid Shares
Voting Joint Holders
Voting Member Unsound Mind
Voting Transmittee
Waiver
Waiver Effective Only Specific Instance Purpose Given
Waiver Exercise Rights
Waiver Pre-emption Rights
Waiver Rights Against
Warranties
Warranty Indemnity Payments
Withdrawal Consent Act Director
Withholding Tax
Written
Xix Other Taxes
Xvi Provisions
Xvii Deferred Revenue
Xviii Income Tax
Xxi Investments
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour